Nilesh Kumar - Dissemin

All papers authored by Nilesh Kumar

This paper was not found in any repository, but could be made available legally by the author.

2021 Ashish Sharma

, Nilesh Kumar

, Nikulaa Parachuri, Baruch D. Kuppermann, Francesco Bandello, Carl D. Regillo, David Boyer, Quan Dong Nguyen

Brolucizumab—foreseeable workflow in the current scenario

Upload

Ashish Sharma

, Nilesh Kumar

, Nikulaa Parachuri, Francesco Bandello, Baruch D. Kuppermann, Anat Loewenstein, Srinivas R. Sadda, David Sarraf

Understanding the Mechanisms of Fluid Development in Age-Related Macular Degeneration

Upload

Ashish Sharma

, Nikulaa Parachuri, Nilesh Kumar

, Francesco Bandello, Baruch D. Kuppermann, Anat Loewenstein, Carl D. Regillo, Usha Chakravarthy

Vortex vein anastomosis and pachychoroid—an evolving understanding

Upload

2020 Ashish Sharma

, Nilesh Kumar

, Nikulaa Parachuri, Srinivas R. Sadda, Giulia Corradetti

, Jeffrey Heier, Adam T. Chin

, David Boyer, Pouya Dayani, Sruthi Arepalli, Peter Kaiser

Correction: Brolucizumab—early real-world experience: BREW study

Upload

Ashish Sharma

, Nikulaa Parachuri, Nilesh Kumar

, Francesco Bandello

, Baruch D. Kuppermann, Anat Loewenstein, Carl Regillo, Usha Chakravarthy

Fluid-based prognostication in n-AMD: Type 3 macular neovascularisation needs an analysis in isolation

Upload

Ashish Sharma

, Nilesh Kumar

, Nikulaa Parachuri, Francesco Bandello, Baruch D. Kuppermann, Anat Loewenstein

Upload

Ashish Sharma

, Nilesh Kumar

, Nikulaa Parachuri, Sonali Singh, Francesco Bandello, Baruch D. Kuppermann, Anat Loewenstein

Upload

Ashish Sharma

, Nikulaa Parachuri, Nilesh Kumar

, Francesco Bandello

, Baruch D. Kuppermann, Anat Loewenstein, Carl D. Regillo, Usha Chakravarthy

Notion of tolerating subretinal fluid in neovascular AMD: understanding the fine print before the injection pause

Upload

Ashish Sharma

, Nilesh Kumar

, Francesco Bandello

, Baruch D. Kuppermann, Anat Loewenstein, Carl D. Regillo

Brolucizumab: the road ahead

Upload

Ashish Sharma

, Nilesh Kumar

, Nikulaa Parachuri, Srinivas R. Sadda, Giulia Corradetti

, Jeffrey Heier, Adam T. Chin

, David Boyer, Pouya Dayani, Sruthi Arepalli, Peter Kaiser

Brolucizumab—early real-world experience: BREW study

Upload

2019 Ashish Sharma

, M. Hafeez Faridi, Nilesh Kumar

, Nikulaa Parachuri, Rohini Sharma, Baruch D. Kuppermann, Francesco Bandello, Anat Loewenstein, Carl D. Regillo

Immunogenicity and efficacy after switching from original Ranibizumab to a Ranibizumab biosimilar: real-world data

Upload

Ashish Sharma

, Nilesh Kumar

, Francesco Bandello, Anat Loewenstein, Baruch D. Kuppermann

Need of education on biosimilars amongst ophthalmologists: combating the nocebo effect

Upload

Ashish Sharma

, Nilesh Kumar

, Baruch D. Kuppermann, Francesco Bandello, Anat Loewenstein

Faricimab: expanding horizon beyond VEGF

Upload

Ashish Sharma

, Nilesh Kumar

, Baruch D. Kuppermann, Francesco Bandello, Anat Loewenstein

Ophthalmic biosimilars and biologics—role of endotoxins

Upload

Ashish Sharma

, Nilesh Kumar

, Baruch D. Kuppermann, Francesco Bandello

Abicipar pegol: the non-monoclonal antibody anti-VEGF

Upload

Ashish Sharma

, Nilesh Kumar

, Baruch D. Kuppermann, Francesco Bandello

Brolucizimab—leading an era of structural revolution for long-term VEGF suppression

Upload

Ashish Sharma

, Nilesh Kumar

, Baruch D. Kuppermann, Anat Loewenstein, Francesco Bandello

Brolucizumab: is extended VEGF suppression on the horizon?

Upload

Ashish Sharma

, Nilesh Kumar

, Baruch D. Kuppermann, Francesco Bandello

, Anat Loewenstein

Understanding biosimilars and its regulatory aspects across the globe: an ophthalmology perspective

Upload

Missing publications? Search for publications with a matching author name.

Researcher

Statistics

Refine

All papers authored by Nilesh Kumar